Engaging with Tribal Communities in Responding to STDs
This webinar taught participants how to develop strategies to engage with tribal communities in responding their STD prevention efforts.
Search Results
Results 16731 - 16740 of 17741
How Schools Can Support HIV Testing Among Adolescents
Information sheet that explains the importance of HIV testing among adolescents.
Sexually Transmitted Disease Surveillance 2018
This report presents statistics and trends for STDs in the United States through 2018.
[Living with Hepatitis B]
The animation educates viewers on topics related to drug-resistant TB and multidrug-resistant TB, such as treatment plans, basic information on multidrug-resistant TB, and the importance of medication adherence.
Hepatitis B Fast Facts
This video illustrates the interactions between TB and HIV, including their impact on the immune system, TB testing, and TB treatment.
El Programma de Terapia Observada Directamente (TOD) [Directly Observed Therapy (DOT) Program]
This fact sheet explains the facts about DOT.
Coordinates 2002: Charting Progress Against AIDS, TB and Malaria
This report discusses the burdens of AIDS, malaria, and TB; assesses the tools used to fight them; identifies barriers to success; and provides statistics on deaths caused by these diseases in 2000.
An Expanded DOTS Framework for Effective Tuberculosis Control
This document reinforces the five essential elements of the DOTS strategy.
MMWR: Cluster of Tuberculosis Cases Among Exotic Dancers and Their Close Contacts--Kansas, 1994-2000
This report describes the results of the investigation of a cluster of TB cases that occurred in Kansas from 1994 to 2000 among women with a history of working as exotic dancers and persons who were close contacts of the dancers.
MMWR: Fatal and Severe Hepatitis Associated with Rifampin and Pyrazinamide for the Treatment of Latent Tuberculosis Infection--New York and Georgia, 2000
This report discusses two cases of latent TB infection in which patients developed severe or fatal hepatitis associated with rifampin-pyrazinamide (RIF-PZA) treatment.